NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

OTC Markets · Medical Devices · USD

Allurion Technologies Inc. (ALUR) Stock Analysis

Allurion Technologies Inc. (ALUR) is a Medical Devices stock listed on OTC Markets and quoted in US Dollar.

ALUR

$1.12

+$0.02 (+1.82%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ALUR with… →

ALUR Key Statistics

As of Sep 4, 2026
Trading
Open
$1.09
Previous Close
$1.10
Day's Range
1.09–1.12
52-Week Range
0.23–8.52
Volume
1.80K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
−0.19
Valuation
Market Cap
$1.12M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.09
EPS (ttm)Profit attributable to each share over the last twelve months.
−60.48
Financials (FY)
Revenue (FY)
$15.23M−52.57%
Net Income (FY)
−$28.76M
Profit marginThe share of revenue left as profit after all costs and taxes.
−264.74%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
1.00M
1-Year Return
−47.29%
Dividend and dates
Avg Volume
8.41K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ALUR Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−8.94%
2025−67.80%

As of September 4, 2026.

ALUR Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$15.23M−$28.76M−188.8%
2024$32.11M−$7.20M−22.4%
2023$53.47M−$82.82M−154.9%
2022$64.21M−$37.74M−58.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$15.23M$9.57M−$30.16M−$28.76M−188.8%
2024$32.11M$21.50M−$50.20M−$7.20M−22.4%
2023$53.47M$41.50M−$79.08M−$82.82M−154.9%
2022$64.21M$50.73M−$32.01M−$37.74M−58.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ALUR Valuation vs Medical Devices Median

Median of 151 stocks
MetricALURMedical Devices medianvs median
P/S ratio0.092.980.0x the median
Profit margin−264.74%−1.69%263.0 pts below

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

The market values Allurion Technologies Inc. (ALUR) at $1.12M. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 38.

The most recent close on file for ALUR is $1.12, dated September 4, 2026. That is +$0.02 (+1.82%) against the previous close. Over the past 52 weeks the price has ranged from $0.23 to $8.52. The latest close sits 386.96% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $15.23M. That is −52.57% against the prior fiscal year, when revenue was $32.11M. The same year closed with a net loss of $28.76M. Profit margin runs at −264.74%. That is 263 percentage points below the Medical Devices median of −1.69%. Trailing earnings per share are −60.48.

Across the 4 fiscal years on file, revenue moves from $64.21M in 2022 to $15.23M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 0.09 times revenue. On price-to-sales that is 0 times the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

The trailing one-year price return is −47.29%. The stored price history starts on January 10, 2025, and the total return since then is −70.68%. The reported beta is −0.19. Annualized volatility over the trailing 1 year is 592.37%.

Growth & Income

The record shows no dividend for ALUR.

2026 is still running; the price is −8.94% year to date. The record holds one complete calendar year, 2025, which returned −67.80%.

Peer Comparison

Allurion Technologies Inc. (ALUR) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Allurion Technologies Inc. ALUR $1.12M —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Allurion Technologies Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Allurion Technologies Inc.

Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program. The company is headquartered in Natick, Massachusetts.

Visit website →